Compare ARCB & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARCB | ENOV |
|---|---|---|
| Founded | 1923 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Fluid Controls |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | N/A | 2008 |
| Metric | ARCB | ENOV |
|---|---|---|
| Price | $86.10 | $27.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 8 |
| Target Price | ★ $92.00 | $48.13 |
| AVG Volume (30 Days) | 408.6K | ★ 907.1K |
| Earning Date | 01-30-2026 | 02-25-2026 |
| Dividend Yield | ★ 0.59% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.20 | N/A |
| Revenue | ★ $4,039,115,000.00 | $2,233,266,000.00 |
| Revenue This Year | N/A | $9.27 |
| Revenue Next Year | $3.67 | $4.65 |
| P/E Ratio | $19.46 | ★ N/A |
| Revenue Growth | N/A | ★ 11.57 |
| 52 Week Low | $55.19 | $25.47 |
| 52 Week High | $103.63 | $49.38 |
| Indicator | ARCB | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 73.55 | 51.51 |
| Support Level | $73.72 | $26.24 |
| Resistance Level | $78.06 | $27.81 |
| Average True Range (ATR) | 2.54 | 1.02 |
| MACD | 0.40 | 0.17 |
| Stochastic Oscillator | 98.61 | 93.20 |
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.